These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 20942785)

  • 1. Genetic determinants of amyotrophic lateral sclerosis as therapeutic targets.
    Bosco DA; Landers JE
    CNS Neurol Disord Drug Targets; 2010 Dec; 9(6):779-90. PubMed ID: 20942785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting Extracellular Cyclophilin A Reduces Neuroinflammation and Extends Survival in a Mouse Model of Amyotrophic Lateral Sclerosis.
    Pasetto L; Pozzi S; Castelnovo M; Basso M; Estevez AG; Fumagalli S; De Simoni MG; Castellaneta V; Bigini P; Restelli E; Chiesa R; Trojsi F; Monsurrò MR; Callea L; Malešević M; Fischer G; Freschi M; Tortarolo M; Bendotti C; Bonetto V
    J Neurosci; 2017 Feb; 37(6):1413-1427. PubMed ID: 28011744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging targets and treatments in amyotrophic lateral sclerosis.
    Zinman L; Cudkowicz M
    Lancet Neurol; 2011 May; 10(5):481-90. PubMed ID: 21511200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular basis of ALS and FTD: implications for translational studies.
    Liščić RM
    Arh Hig Rada Toksikol; 2015 Dec; 66(4):285-90. PubMed ID: 26751860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenic Genome Signatures That Damage Motor Neurons in Amyotrophic Lateral Sclerosis.
    Yousefian-Jazi A; Seol Y; Kim J; Ryu HL; Lee J; Ryu H
    Cells; 2020 Dec; 9(12):. PubMed ID: 33333804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations.
    Mackenzie IR; Bigio EH; Ince PG; Geser F; Neumann M; Cairns NJ; Kwong LK; Forman MS; Ravits J; Stewart H; Eisen A; McClusky L; Kretzschmar HA; Monoranu CM; Highley JR; Kirby J; Siddique T; Shaw PJ; Lee VM; Trojanowski JQ
    Ann Neurol; 2007 May; 61(5):427-34. PubMed ID: 17469116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current nervous system related drug targets for the treatment of amyotrophic lateral sclerosis.
    Pawlyk AC; Cassel JA; Reitz AB
    Curr Pharm Des; 2010; 16(18):2053-73. PubMed ID: 20370663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Development of motor neuron restorative therapy in amyotrophic lateral sclerosis using hepatocyte growth factor].
    Aoki M; Warita H; Suzuki N; Itoyama Y
    Rinsho Shinkeigaku; 2009 Nov; 49(11):814-7. PubMed ID: 20030218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis, pathogenesis and therapeutic targets in amyotrophic lateral sclerosis.
    Costa J; Gomes C; de Carvalho M
    CNS Neurol Disord Drug Targets; 2010 Dec; 9(6):764-78. PubMed ID: 20942786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective Genetic Overlap Between Amyotrophic Lateral Sclerosis and Diseases of the Frontotemporal Dementia Spectrum.
    Karch CM; Wen N; Fan CC; Yokoyama JS; Kouri N; Ross OA; Höglinger G; Müller U; Ferrari R; Hardy J; Schellenberg GD; Sleiman PM; Momeni P; Hess CP; Miller BL; Sharma M; Van Deerlin V; Smeland OB; Andreassen OA; Dale AM; Desikan RS;
    JAMA Neurol; 2018 Jul; 75(7):860-875. PubMed ID: 29630712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delayed disease onset and extended survival in the SOD1G93A rat model of amyotrophic lateral sclerosis after suppression of mutant SOD1 in the motor cortex.
    Thomsen GM; Gowing G; Latter J; Chen M; Vit JP; Staggenborg K; Avalos P; Alkaslasi M; Ferraiuolo L; Likhite S; Kaspar BK; Svendsen CN
    J Neurosci; 2014 Nov; 34(47):15587-600. PubMed ID: 25411487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. UNC13A is a modifier of survival in amyotrophic lateral sclerosis.
    Diekstra FP; van Vught PW; van Rheenen W; Koppers M; Pasterkamp RJ; van Es MA; Schelhaas HJ; de Visser M; Robberecht W; Van Damme P; Andersen PM; van den Berg LH; Veldink JH
    Neurobiol Aging; 2012 Mar; 33(3):630.e3-8. PubMed ID: 22118904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuronal death in amyotrophic lateral sclerosis (ALS): what can we learn from genetics?
    Sreedharan J
    CNS Neurol Disord Drug Targets; 2010 Jul; 9(3):259-67. PubMed ID: 20406185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic ablation of phospholipase C delta 1 increases survival in SOD1(G93A) mice.
    Staats KA; Van Helleputte L; Jones AR; Bento-Abreu A; Van Hoecke A; Shatunov A; Simpson CL; Lemmens R; Jaspers T; Fukami K; Nakamura Y; Brown RH; Van Damme P; Liston A; Robberecht W; Al-Chalabi A; Van Den Bosch L
    Neurobiol Dis; 2013 Dec; 60():11-7. PubMed ID: 23969236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. De novo FUS gene mutations are associated with juvenile-onset sporadic amyotrophic lateral sclerosis in China.
    Zou ZY; Cui LY; Sun Q; Li XG; Liu MS; Xu Y; Zhou Y; Yang XZ
    Neurobiol Aging; 2013 Apr; 34(4):1312.e1-8. PubMed ID: 23046859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathological Modification of TDP-43 in Amyotrophic Lateral Sclerosis with SOD1 Mutations.
    Jeon GS; Shim YM; Lee DY; Kim JS; Kang M; Ahn SH; Shin JY; Geum D; Hong YH; Sung JJ
    Mol Neurobiol; 2019 Mar; 56(3):2007-2021. PubMed ID: 29982983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FUS mutations in amyotrophic lateral sclerosis: clinical, pathological, neurophysiological and genetic analysis.
    Blair IP; Williams KL; Warraich ST; Durnall JC; Thoeng AD; Manavis J; Blumbergs PC; Vucic S; Kiernan MC; Nicholson GA
    J Neurol Neurosurg Psychiatry; 2010 Jun; 81(6):639-45. PubMed ID: 19965854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modelling amyotrophic lateral sclerosis: progress and possibilities.
    Van Damme P; Robberecht W; Van Den Bosch L
    Dis Model Mech; 2017 May; 10(5):537-549. PubMed ID: 28468939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. From Mouse Models to Human Disease: An Approach for Amyotrophic Lateral Sclerosis.
    Alrafiah AR
    In Vivo; 2018; 32(5):983-998. PubMed ID: 30150420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological treatment of ALS.
    Münch C; Ludolph AC
    Neurol Neurochir Pol; 2001; 35(1 Suppl):41-50. PubMed ID: 11732279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.